ATE100438T1 - Phenethanolaminderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. - Google Patents
Phenethanolaminderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.Info
- Publication number
- ATE100438T1 ATE100438T1 AT90304327T AT90304327T ATE100438T1 AT E100438 T1 ATE100438 T1 AT E100438T1 AT 90304327 T AT90304327 T AT 90304327T AT 90304327 T AT90304327 T AT 90304327T AT E100438 T1 ATE100438 T1 AT E100438T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- proviso
- compounds
- carbon atoms
- sum total
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 abstract 1
- 125000006590 (C2-C6) alkenylene group Chemical group 0.000 abstract 1
- 125000006591 (C2-C6) alkynylene group Chemical group 0.000 abstract 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- 102100039705 Beta-2 adrenergic receptor Human genes 0.000 abstract 1
- 101710152983 Beta-2 adrenergic receptor Proteins 0.000 abstract 1
- 206010006458 Bronchitis chronic Diseases 0.000 abstract 1
- 206010062109 Reversible airways obstruction Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 208000007451 chronic bronchitis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/31—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
- C07C311/35—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898909273A GB8909273D0 (en) | 1989-04-24 | 1989-04-24 | Chemical compounds |
| EP90304327A EP0401966B1 (de) | 1989-04-24 | 1990-04-23 | Phenethanolaminderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE100438T1 true ATE100438T1 (de) | 1994-02-15 |
Family
ID=10655605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90304327T ATE100438T1 (de) | 1989-04-24 | 1990-04-23 | Phenethanolaminderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5066678A (de) |
| EP (1) | EP0401966B1 (de) |
| JP (1) | JPH0372448A (de) |
| AT (1) | ATE100438T1 (de) |
| AU (1) | AU631865B2 (de) |
| CA (1) | CA2015188A1 (de) |
| DE (1) | DE69006107T2 (de) |
| GB (1) | GB8909273D0 (de) |
| NZ (1) | NZ233414A (de) |
| PT (1) | PT93844A (de) |
| ZA (1) | ZA903049B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5451677A (en) * | 1993-02-09 | 1995-09-19 | Merck & Co., Inc. | Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity |
| US5775329A (en) * | 1995-06-07 | 1998-07-07 | Gensia, Inc. | Method and compounds for diagnosing coronary artery disease |
| GB0103630D0 (en) | 2001-02-14 | 2001-03-28 | Glaxo Group Ltd | Chemical compounds |
| WO2002076933A1 (en) * | 2001-03-22 | 2002-10-03 | Glaxo Group Limited | Formailide derivatives as beta2-adrenoreceptor agonists |
| BRPI0212455B8 (pt) | 2001-09-14 | 2021-05-25 | Glaxo Group Ltd | composto derivado de fenetanolamina para o tratamento de doenças respiratórias, formulação farmacêutica, combinação, e, uso do mesmo |
| GB0217225D0 (en) | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicinal compounds |
| GB0303396D0 (en) * | 2003-02-14 | 2003-03-19 | Glaxo Group Ltd | Medicinal compounds |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2900415A (en) * | 1954-12-14 | 1959-08-18 | Lakeside Lab Inc | Synthesized antispasmodic compounds |
| FR148F (de) * | 1962-01-24 | |||
| DE1618005A1 (de) * | 1966-09-22 | 1971-09-09 | Thomae Gmbh Dr K | Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen |
| GB1200886A (en) * | 1966-09-23 | 1970-08-05 | Allen & Hanburys Ltd | Phenylaminoethanol derivatives |
| GB1214012A (en) * | 1967-12-21 | 1970-11-25 | Allen & Hanburys Ltd | Phenylethanolamines |
| DE3061205D1 (en) * | 1979-06-16 | 1983-01-05 | Beecham Group Plc | Secondary amines, their preparation and use in pharmaceutical compositions |
| US4404222A (en) * | 1980-08-25 | 1983-09-13 | American Cyanamid Company | Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and improving the efficiency of feed utilization thereby |
| ZW6584A1 (en) * | 1983-04-18 | 1985-04-17 | Glaxo Group Ltd | Phenethanolamine derivatives |
| SE8503466L (sv) * | 1984-07-13 | 1986-01-14 | Glaxo Group Ltd | Aminofenolforeningar |
| GB8426191D0 (en) * | 1984-10-17 | 1984-11-21 | Glaxo Holdings Ltd | Chemical compounds |
| EP0223410A3 (de) * | 1985-10-16 | 1987-11-19 | Glaxo Group Limited | Ethanolaminderivate |
| EP0278727A3 (de) * | 1987-02-10 | 1990-03-14 | Glaxo Group Limited | 1-(4-Amino-3-chloro-5-trifluoromethylphenyl)-2-(substituierte amino)ethanol-Derivate und ihre Verwendung bei der Behandlung von Lungenkrankheiten |
| EP0286242A3 (de) * | 1987-03-12 | 1989-08-09 | Glaxo Group Limited | Ethanolamin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Verbindungen |
| DE3714484A1 (de) * | 1987-04-30 | 1988-11-10 | Bayer Ag | Neue aminophenylethylamin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als leistungsfoerderer |
-
1989
- 1989-04-24 GB GB898909273A patent/GB8909273D0/en active Pending
-
1990
- 1990-04-23 NZ NZ233414A patent/NZ233414A/xx unknown
- 1990-04-23 CA CA002015188A patent/CA2015188A1/en not_active Abandoned
- 1990-04-23 PT PT93844A patent/PT93844A/pt not_active Application Discontinuation
- 1990-04-23 AU AU53777/90A patent/AU631865B2/en not_active Ceased
- 1990-04-23 ZA ZA903049A patent/ZA903049B/xx unknown
- 1990-04-23 EP EP90304327A patent/EP0401966B1/de not_active Expired - Lifetime
- 1990-04-23 JP JP2107323A patent/JPH0372448A/ja active Pending
- 1990-04-23 DE DE90304327T patent/DE69006107T2/de not_active Expired - Fee Related
- 1990-04-23 US US07/512,874 patent/US5066678A/en not_active Expired - Fee Related
- 1990-04-23 AT AT90304327T patent/ATE100438T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT93844A (pt) | 1990-11-20 |
| CA2015188A1 (en) | 1990-10-24 |
| JPH0372448A (ja) | 1991-03-27 |
| EP0401966A1 (de) | 1990-12-12 |
| DE69006107D1 (de) | 1994-03-03 |
| AU631865B2 (en) | 1992-12-10 |
| US5066678A (en) | 1991-11-19 |
| GB8909273D0 (en) | 1989-06-07 |
| EP0401966B1 (de) | 1994-01-19 |
| DE69006107T2 (de) | 1994-05-05 |
| NZ233414A (en) | 1992-09-25 |
| ZA903049B (en) | 1991-05-29 |
| AU5377790A (en) | 1990-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2669336B1 (fr) | Nouveaux derives d'oxazolo pyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| DE3584120D1 (de) | Tetrapyrrolverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| NO170280C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater | |
| ATE113284T1 (de) | Purinverbindungen, verfahren zu ihrer herstellung und pharmazeutische präparate. | |
| ES8603870A1 (es) | Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol. | |
| GR3024956T3 (en) | Substituted (5,6)-dihydronaphthalenyl compounds having retinoid-like activity. | |
| KR970704710A (ko) | 트리아졸 화합물 및 도파민 D₃리간드로서의 그의 용도(Triazole Compounds and Their Use as Dopamine-D₃-Ligands) | |
| ATE89547T1 (de) | Dopamin-vorlaeufer. | |
| CA2015475A1 (en) | Treating agent for osteoarthritis | |
| EP0398720A3 (de) | Piperazin-Derivate | |
| HU900656D0 (en) | Process for producing anti-phlogistic aryl compounds | |
| ATE100438T1 (de) | Phenethanolaminderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| ATE109470T1 (de) | Phenylpyridon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ES8308833A1 (es) | "un metodo para la preparacion de 3-fenil-1-indanaminas". | |
| FR2691149B1 (fr) | Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| GR3006606T3 (de) | ||
| CA2038025A1 (en) | Optically active alkylenedioxybenzene derivatives and their use in therapy | |
| DE69307071D1 (de) | Kardioaktive 17B-aryl und 17B-heterozyklyl-5-beta,14-beta-Androstan-Derivate,ein Verfahren zu ihrer Herstellung und pharmazeutische Phäparate davon | |
| ATE178797T1 (de) | Neue morphinzusammensetzungen für iontophoretische verabreichung | |
| ES533657A0 (es) | Un procedimiento para la preparacion de nuevos derivados de pirrolo-(2,1-a)isoquilonina. | |
| KR870001189A (ko) | 1,4-벤조디옥산 유도체의 제조방법 | |
| FR2707982B1 (fr) | Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
| ATE101119T1 (de) | Butensaeure-amide, deren salze, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung. | |
| ATE46510T1 (de) | Ergolinderivate, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und verwendung. | |
| FR2691967B1 (fr) | Nouveaux composes pyrrolothienopyraziniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |